Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2022-11-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（熊焰）
Board/Management Information Classification · 95% confidence The document is a declaration statement by an independent director candidate of a company, affirming compliance with various legal and regulatory requirements for the position. It is a formal statement related to board/management qualifications and independence, not a financial report, audit, or general regulatory filing. It does not announce voting results, nor is it a proxy solicitation or remuneration report. The content is specifically about board/management information concerning an independent director candidate's qualifications and declarations. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3494 characters, which is consistent with a detailed declaration statement rather than a brief announcement or a full report.
2022-11-22 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement from 嘉事堂药业股份有限公司 regarding the election of a new supervisory board (监事会换届选举). It details the nomination of candidates for the seventh supervisory board, their qualifications, and compliance with relevant laws and regulations. There is no financial data, no discussion of financial results, no mention of annual or interim reports, and no indication of a shareholder vote result. The document is a formal announcement about changes in the supervisory board members, which falls under management or board information disclosures. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4223 characters, which is sufficient for a detailed announcement but not a full report.
2022-11-22 Chinese
独立董事提名人声明（熊焰）
Board/Management Information Classification · 100% confidence The document is a public statement nominating an independent director candidate for the company's board. It contains detailed declarations about the nominee's qualifications and compliance with various regulatory requirements. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically about a director nomination. The document length is 3475 characters, which is relatively short and consistent with a nomination statement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2022-11-22 Chinese
独立董事关于第六届董事会第二十二次临时会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the board of directors' re-election process and candidate qualifications for the company's seventh board. It references compliance with regulatory guidelines and company bylaws, and it is related to board/management changes. The document is not a full report but an opinion statement on board nominations, which fits the category of Board/Management Information (MANG). The document length is short and focused on management/board changes, not financial results or other report types.
2022-11-22 Chinese
第六届董事会第二十一次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of a board meeting resolution regarding the appointment of a company vice president. It details the meeting date, attendance, voting results, and references related announcements. There is no financial data, audit information, or report content. The document fits the category of Board/Management Information (MANG) as it concerns changes in senior management.
2022-11-09 Chinese
关于聘任公司副总裁的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new company vice president, including details about the individual's qualifications and the board's approval. It does not contain financial data, audit information, or regulatory filings related to financial performance. It is clearly about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management appointment, confirming this classification.
2022-11-09 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.